Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
89,506,929
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
20,469,589
-
Shares change
-
-1,041,073
-
Total reported value, excl. options
-
$58,338,295
-
Value change
-
-$3,166,998
-
Put/Call ratio
-
6100%
-
Number of buys
-
22
-
Number of sells
-
18
-
Price
-
$2.85
Institutional Holders of Milestone Pharmaceuticals Inc. - Common Stock (MIST) as of Q2 2023
57 filings reported holding MIST - Milestone Pharmaceuticals Inc. - Common Stock as of 30 Jun 2023.
Milestone Pharmaceuticals Inc. - Common Stock (MIST) had 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 20,469,589 shares of stock of the company.
Largest 10 holders included RTW INVESTMENTS, LP, BlackRock Inc., GOLDMAN SACHS GROUP INC, VR Adviser, LLC, MILLENNIUM MANAGEMENT LLC, Bleichroeder LP, Alta Fundamental Advisers LLC, MORGAN STANLEY, BARCLAYS PLC, and Boxer Capital, LLC.
This table shows the top 46 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.